Medical News

RSS

Australian CSIRO, GE Healthcare partner for investigational PET imaging agent

GE Healthcare today announced a collaboration with Australian Commonwealth Scientific and Industrial Research Organisation (CSIRO) involving its investigational PET imaging agent [18F flutemetamol].

12 Jun 2012

Opinion pieces published in advance of 'Child Survival Call to Action' event to take place in Washington

The following are summaries of several opinion pieces published in anticipation of the Child Survival Call to Action event to be held on June 14-15 in Washington, D.C. Convened by the Governments of United States, Ethiopia and India, and organized in close collaboration with UNICEF, the event will focus on ending preventable child death through the survival of newborns, children and mothers and will convene 700 prominent leaders from government, the private sector, faith-based organizations and civil society to kick off a long-term, focused effort to save children's lives.

12 Jun 2012

Genzyme files LEMTRADA sBLA and MAA with FDA, EMA for treatment of RMS

Genzyme, a Sanofi company, today announced that the company has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a marketing authorization application (MAA) to the European Medicines Agency (EMA) seeking approval of LEMTRADA (alemtuzumab) for treatment of relapsing multiple sclerosis (RMS).

12 Jun 2012

Mindfulness can help cancer patients with anxiety and depression

When being diagnosed with cancer, people will naturally worry about their future, their family and about dying. Actually, no less than 35-40% of cancer patients suffer from significant anxiety and depression symptoms. An interdisciplinary research project carried out between Aarhus University, Business and Social Sciences and Aarhus University Hospital and the Danish Cancer Society now shows that mindfulness can help cancer those patients suffering from anxiety and depression.

12 Jun 2012

Study documents altruistic behavior by human embryonic stem cells

When most groups of mammalian cells are faced with a shortage of nutrients or oxygen, the phrase "every man for himself" is more apt than "all for one, one for all." Unlike colonies of bacteria, which often cooperate to thrive as a group, mammalian cells have never been observed to help one another out. But a new study led by a researcher at the Stanford University School of Medicine has shown that certain human embryonic stem cells, in times of stress, produce molecules that not only benefit themselves, but also help nearby cells survive.

12 Jun 2012

Scientists discover new genetic information linked with shigellosis

Scientists have found new genetic information that shows how harmful bacteria cause the acute diarrheal disease shigellosis, which kills more than a million people worldwide each year.

12 Jun 2012

Anthem Blue Cross president Pam Kehaly: Wrestling with rising medical costs, keeping coverage affordable

Pam Kehaly, 51, is president of Anthem Blue Cross in California, the state's largest for-profit health insurer and a unit of WellPoint Inc. The executive said she wrestles with how to control rising medical costs and find ways to keep coverage affordable for millions of employers and consumers.

12 Jun 2012

RGS proteins play an essential role in night blindness

In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute have identified several proteins that help regulate cells' response to light-and the development of night blindness, a rare disease that abolishes the ability to see in dim light.

12 Jun 2012

Study shows how ruthenium-based drugs may be more effective at fighting cancer cells

A new study by University of Kentucky researchers shows how light and strained ruthenium-based drugs may be more effective at fighting cancer cells and less toxic to healthy cells than a similar and widely used drug.

12 Jun 2012

Researcher uncovers link between pro athlete's longevity and sleepiness

Coaches, owners and fantasy-league traders take note: Sleep researcher W. Christopher Winter, MD, has uncovered a link between a pro athlete's longevity and the degree of sleepiness experienced in the daytime.

12 Jun 2012

Gay and lesbian couples more likely to mutually influence each other's health habits

Women bear the brunt of being the health police in heterosexual marriages, but gay and lesbian couples are more likely to mutually influence each other's health habits - for better or for worse. The findings are reported in the June issue of the journal, Social Science & Medicine.

12 Jun 2012

International summit to be held in London aims to provide 120M women with family planning services

The Guardian reports on a "major summit" to be held in London on July 11, which "aims to provide access to family planning to 120 million women at an estimated cost of $4 billion." According to the newspaper, the summit "is being organized by the Bill & Melinda Gates Foundation and the British government's department for international development (DFID)," and "between 20 and 25 countries are scheduled to attend, including the U.S., India, Ethiopia, Nigeria and Tanzania."

12 Jun 2012

Sucrose and menthol act independently to reduce coughing

Millions of Americans reach for their cough drops or syrup at the first sign of a cough. However, scientists are unsure if and how these popular remedies work. Now, new findings from the Monell Center suggest that sucrose and menthol, ingredients commonly regarded as flavorings in these preparations, each act independently to reduce coughing.

12 Jun 2012

ABM treatments can address childhood anxiety

According to the Anxiety and Depression Association of America, one in eight children suffers from an anxiety disorder. And because many anxious children turn into severely anxious adults, early intervention can have a major impact on a patient's life trajectory. The understandable reluctance to use psychiatric medications when it comes to children means child psychologists are always searching for viable therapeutic alternatives.

12 Jun 2012

RVO advances PresbyLens into final phase of trial for treatment of presbyopia

ReVision Optics, Inc. (RVO), a leader in implantable inlay technology to treat presbyopia, announces the advancement of its proprietary product PresbyLens into the final phase of its U.S. clinical trial under an Investigational Device Exemption

12 Jun 2012

Individuals on statins more likely to experience fatigue with exertion

In a study of more than 1,000 adults, researchers at the University of California, San Diego, found that individuals taking cholesterol-lowering statin drugs are more likely than non-users to experience decreased energy, fatigue upon exertion, or both. The researchers suggest that these findings should be taken into account by doctors when weighing risk versus benefit in prescribing statins.

12 Jun 2012

Enzo Biochem third quarter total revenue increases 4% to $26 million

Enzo Biochem, Inc. today reported results for the fiscal third quarter ended April 30, 2012.

12 Jun 2012

Children of older fathers inherit longer telomeres

If your father and grandfather waited until they were older before reproducing, you might experience life-extending benefits. Biologists assume that a slow pace of aging requires that the body invest more resources in repairing cells and tissues.

12 Jun 2012

MVP receives European patent for PEG conjugates of interferon-beta-1b to treat MS

Mountain View Pharmaceuticals, Inc. announced its receipt of European Patent No. 1 667 708 B1, titled "Polyethylene Glycol Conjugates of Interferon-beta-1b with Enhanced in vitro Biological Potency."

12 Jun 2012

BioMed Realty enters definitive agreement to acquire Granta Park

BioMed Realty Trust, Inc. today announced that it has entered into a definitive agreement to acquire Granta Park, comprising eleven laboratory and office buildings and a total of approximately 472,200 square feet of space, as well as approximately 138,400 square feet of development and expansion rights, in Cambridge, United Kingdom. The purchase price for the property is 126.8 million pounds, or approximately $196.0 million, excluding transaction costs.

11 Jun 2012